Recombinant Anti-CD38 × Anti-CD3 Bispecific Antibody (Triplebody) (CAT#: TRIAB-LC001)

The anti-CD3/CD33 antibody targets both CD3 and CD34. By depleting CD38+ cells while minimizing the CRS effects, the bispecific antibody can be potentially used in the treatment of cancers.

Specific Inquiry
  • Size:
  • Conjugation:
  • Datasheet
  • MSDS
  • COA


  • Target
  • CD38 & CD3
  • Type
  • Triplebody
  • Species Reactivity
  • Human
  • Target 1
  • CD38
  • Host Species 1
  • Human
  • Target 2
  • CD3
  • Host Species 2
  • Human
  • Application
  • SPR
  • Related Disease
  • Cancer, Autoimmune disease.


  • Target 1
  • CD38
  • Alternative Names
  • CD38; CD38 molecule; T10; ADPRC 1; ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1; cADPr hydrolase 1; CD38 antigen (p45); NAD(+) nucleosidase; ADP-ribosyl cyclase 1; cyclic ADP-ribose hydrolase 1; 2-phospho-ADP-ribosyl cyclase; 2-phospho-cyclic-ADP-ribose transferase; 2-phospho-ADP-ribosyl cyclase/2-phospho-cyclic-ADP-ribose transferase
  • Target 2
  • CD3
  • Alternative Names
  • CD3; CD3 T-Cell Co-receptor;CD3D; CD3E; CD3G


Download resources about recombinant antibody development and antibody engineering to boost your research.

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TRIAB-LC001. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2023 Creative Biolabs. All Rights Reserved.
  • 0
  • 0

    Go to compare